Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have been given a consensus rating of “Buy” by the seventeen research firms that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is €77.63 ($90.26).

A number of brokerages have recently commented on FME. UBS Group set a €90.00 ($104.65) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, October 29th. Jefferies Financial Group set a €69.00 ($80.23) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Tuesday, October 29th. Bank of America set a €85.00 ($98.84) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Friday, November 1st. Credit Suisse Group set a €71.00 ($82.56) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Friday, October 18th. Finally, Deutsche Bank set a €100.00 ($116.28) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Wednesday, October 30th.

Shares of Fresenius Medical Care AG & Co. KGaA stock traded up €0.94 ($1.09) during trading on Monday, reaching €66.84 ($77.72). The stock had a trading volume of 534,453 shares, compared to its average volume of 704,197. The company has a market capitalization of $20.08 billion and a price-to-earnings ratio of 15.90. The stock has a fifty day moving average price of €62.20 and a two-hundred day moving average price of €65.47. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €55.44 ($64.47) and a 52 week high of €76.68 ($89.16). The company has a current ratio of 0.98, a quick ratio of 0.62 and a debt-to-equity ratio of 101.27.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: What is the Difference Between Common Shares and Convertible Shares?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.